Antitumor Effect of Bleomycin Nanoaerosol in Murine Carcinoma Model
Authors:
- Saida S. KarshievaSKSaida S. Karshieva
- Gulalek BabayevaGBGulalek Babayeva
- Vadim S. PokrovskyVPVadim S. Pokrovsky
- Yuri M. ShlyapnikovYSYuri M. Shlyapnikov
- Elena A. ShlyapnikovaESElena A. Shlyapnikova
- Anna E. BugrovaABAnna E. Bugrova
- Alexey S. KononikhinAlexey S. Kononikhin
- Evgeny N. NikolaevEvgeny N. Nikolaev
- Igor L. KanevIKIgor L. Kanev
Open Access
Abstract
Bleomycin, which is widely used as an antitumor agent, possesses serious adverse effects such as pulmonary toxicity. Local nanoaerosol deposition for lung cancer treatment is a promising alternative to drug delivery to lung lesions. The aim of this work is to test the hypothesis that bleomycin nanoaerosol can be effectively used to treat multiple lung metastases. To obtain bleomycin nanoaerosol, an aerosol generator based on electrospray of a solution of a nonvolatile substance with gas-phase neutralization of charged aerosol particles was used. Lung metastases in murine Lewis lung carcinoma and B16 melanoma animal models were counted. The effect of inhaled bleomycin nanoparticles on the number and volume of metastases, as well as pulmonary side effects, was investigated. Using a mouse exposure chamber, the dose-dependent effect of inhaled bleomycin on tumor volume was evaluated in comparison with intraperitoneal administration. Bleomycin nanoaerosol reduced the volume of metastases and produced a higher antitumor effect at much lower doses. It has been established that long-term exposure to nanoaerosol with a low dose of bleomycin is capable of suppressing cancer cell growth. The treatment was well tolerated. In the lungs, minor changes were found in the form of focal-diffuse infiltration of the lung parenchyma.Keywords
Funding Information
- State Budjet Project (#075-01027-22-00, 075-10-2019-083)
- Ministry of Science and Higher Education of the Russian Federation (#075-01027-22-00, 075-10-2019-083)
This publication has 52 references indexed in Scilit:
- Inhalable nanoparticles, a non-invasive approach to treat lung cancer in a mouse modelJournal of Controlled Release, 2011
- Preparation of 5-fluorouracil nanoparticles by supercritical antisolvents for pulmonary deliveryInternational Journal of Nanomedicine, 2010
- Ultrasonic nebulization platforms for pulmonary drug deliveryExpert Opinion on Drug Delivery, 2010
- The use of biotinylated-EGF-modified gelatin nanoparticle carrier to enhance cisplatin accumulation in cancerous lungs via inhalationBiomaterials, 2009
- TGF‐β–induced fibrosis and SMAD signaling: oligo decoys as natural therapeutics for inhibition of tissue fibrosis and scarringWound Repair and Regeneration, 2007
- Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine ParticlesEnvironmental Health Perspectives, 2005
- Lymphatic Uptake of Pulmonary Delivered Radiolabelled Solid Lipid NanoparticlesJournal of Drug Targeting, 2002
- Block copolymer micelles for drug delivery: loading and release of doxorubicinJournal of Controlled Release, 1997
- A Multiple-Path Model of Particle Deposition in the Rat LungFundamental and Applied Toxicology, 1995
- An investigation of possible models for the production of progressive pulmonary fibrosis in the rat. The effects of repeated intratracheal instillation of bleomycinToxicology, 1988